Archive for: April 2008

AFP - While chemotherapy can remove breast cancer tumors, it fails to root out the stem cells that can revive the cancer, researchers said in a study published Tuesday.

HealthDay - MONDAY, April 21 (HealthDay News) -- Treatment with a single, commonly used chemotherapy drug causes lingering memory problems and other cognitive difficulties, a common and unpleasant side effect called "chemo brain," a new study has found.

Jacob Rubin, operator of Leben Home for Adults in Elmhurst, NY, home for mentally ill, is forced to step down following revelation that 24 residents underwent often unnecessary prostate surgery

Reuters - impairments in memory and in thinking, or "cognition," that have been attributed to chemotherapy -- was not seen in two studies of women being treated for breast cancer, according to a presentation at the 60th annual meeting of the American Academy of Neurology in Chicago..

HealthDay - TUESDAY, April 15 (HealthDay News) -- Adding the cancer drug Avastin to radiation and chemotherapy improves results for patients with rectal cancer.

HealthDay - TUESDAY, April 15 (HealthDay News) -- The stress of being diagnosed with breast cancer -- not the chemotherapy treatment to combat it -- may be responsible for patient complaints about problems with memory and concentration, two new studies suggest.

HealthDay - MONDAY, April 14 (HealthDay News) -- Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer.

Reuters - The combination of anti-inflammatory and cholesterol-lowering drugs may be able to stop the progression of prostate cancer, according to new research so far carried out only in mice.

HealthDay - MONDAY, April 14 (HealthDay News) -- Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer.

HealthDay - TUESDAY, April 8 (HealthDay News) -- Interrupting communication between cancer cells and cells that promote inflammation blocks an early step in prostate cancer cell's spread, a U.S. study finds.